opnMe Market Share Analysis for July 2026

Science and Education > Biology

Domainopnme.com

Year Founded--

Employees> 10001

Annual Revenue$2M - $5M

opnMe

opnMe (including company regionals)

opnme.com

See more website traffic and engagement information

opnMe Revenue up to July 2026 is 2M - 5M

revenue generated by opnMe top domains

opnMe top domains revenue over 3 years

Revenue for opnMe top domains

opnme.com2M - 5M

See more with Sales Intelligence

Total visits to opnMe's top domains

Understand opnMe market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

opnme.com18.7K

See more with Sales Intelligence

Avg. visit duration in opnMe's top domains

Analyze opnMe engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

opnme.com00:00:31

See more with Sales Intelligence

Avg. pageviews on opnMe's top domains

See how opnMe keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

opnme.com1.98

See more with Sales Intelligence

opnMe top competitors by domain

Top similar sites in July 2026, ranked by their affinity

crscube.ioCompany NameCRScubeEmployees51 - 200HQKorea, Republic of, MapoAnnual revenue$5M - $10MTotal visits31.7KHealth > Medicine

Top technologies used by opnMe

These are the website technologies, by industry, used by opnMe top domains

Content Management System (5)

WordPress

Conversion & Analytics (5)

New Relic

Mobile (3)

Meta Viewport

Audio Video Media (2)

VideoJS

More Technologies

9

See all

News & Signals from opnMe

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBoehringer Ingelheim International partners with Germanstrias.The biopharmaceutical company Boehringer Ingelheim has signed a new collaboration agreement with the Germans Trias i Pujol Research Institute (IGTP), launching a new research project focused on evaluating the potential benefits of a new molecule targeting the cardio-renal-metabolic axis.

NewsBoehringer Ingelheim International expands facilities to Athens, Georgia, United States, Northern America, Americas.Boehringer Ingelheim announced the grand opening of its newly expanded research and development facility in Athens, Georgia.

NewsBoehringer Ingelheim International launches 54 calls for proposals.Opnme has launched 54 calls for proposals as part of its collaborative research initiatives (Molecules for collaboration and opn2EXPERTS) that have resulted in almost 120 research collaborations.